Qing Wen Bai Du Yin (Clear Epidemics and Overcome Toxins Decoction)

Actions

Indications

Western Uses:

• What is Qing Wen Bai Du Yin used for in modern practice?

  In modern practice Qing Wen Bai Du Yin is referenced for the traditional pattern of severe, feverish epidemic illness with rash or bleeding tendency — historically applied to conditions such as epidemic febrile diseases, scarlet fever, and hemorrhagic presentations, and referenced in more recent Chinese clinical literature alongside conventional care for sepsis and, during 2020, as an adjunctive consideration in COVID-19 protocols because of its traditional fire-toxin-draining, blood-cooling action.

  These biomedical correlates are offered as a reference to the formula's traditional use, not as a claim that it treats any disease. The available research is overwhelmingly mechanistic/preclinical and a sepsis systematic-review protocol; robust completed clinical-trial evidence in English-language literature is limited (see research). Any use for a diagnosed condition, especially a critical illness such as sepsis, belongs with a qualified practitioner and appropriate emergency medical care — this formula addresses a traditionally life-threatening pattern and was never intended as a stand-alone home remedy.

  Source: traditional-use correlates summarized from Bensky & Barolet, Formulas & Strategies, and the research literature below; reference only, not a treatment claim.

Originally Appeared In:

• Achievements Regarding Epidemic Rashes (Yi Zhen Yi De)

Notes:

• How is Qing Wen Bai Du Yin different from Bai Hu Tang, Huang Lian Jie Du Tang, and Xi Jiao Di Huang Tang?

  Qing Wen Bai Du Yin is literally built from the cores of these three formulas at once — it is indicated only when heat has overwhelmed both the qi level and the blood level simultaneously, which is more severe than any one of its parent formulas treats alone.

  • vs Bai Hu Tang: Bai Hu Tang clears qi-level heat (high fever, thirst, sweating) but does not address blood-level toxin — add the blood-cooling, toxin-resolving herbs when macules or bleeding appear.
  • vs Huang Lian Jie Du Tang: Huang Lian Jie Du Tang drains fire toxin from all three burners but has no strong qi-level heat-clearer or blood-cooling action — appropriate for fire-toxin without the very high fever or blood-level bleeding/rash.
  • vs Xi Jiao Di Huang Tang: Xi Jiao Di Huang Tang cools and invigorates the blood for nutritive/blood-level heat but lacks a strong qi-level fire-drainer — used when blood-level signs (rash, bleeding, dark tongue) dominate without severe qi-level fever.
  • vs Qing Ying Tang: Qing Ying Tang clears heat at the nutritive (ying) level with a gentler yin-nourishing emphasis and no comparably aggressive qi-level fire-draining dose of Shi Gao — reserved for a lighter nutritive-level pattern than the qi-and-blood crisis Qing Wen Bai Du Yin addresses.

  Common modifications: add Da Huang for severe toxin with constipation, to purge fire toxin downward; add Jin Yin Hua and/or Huang Bai for more pronounced fire-toxin (completing the four-herb Huang Lian Jie Du Tang); reduce the Shi Gao dose and emphasize the blood-cooling herbs once the qi-level fever has eased but blood-level signs persist.

  Source: Bensky & Barolet, Formulas & Strategies (formula comparisons and modification logic).

Clinical Studies & Research:

• Is there modern research on Qing Wen Bai Du Yin?

  Yes, but it is concentrated in network-pharmacology/mechanistic studies, quality-control chemistry, and a registered-but-unreported sepsis review protocol — not completed randomized clinical trials. Interest increased in 2020, when the formula (referenced as Qingwen Baidu Decoction/Yin, QBD) was discussed as a candidate adjunctive therapy for COVID-19 based on its traditional antipyretic, blood-cooling, and toxin-resolving action.

  • Cytokine storm (network pharmacology): a 2020 network-pharmacology analysis identified core targets (including NFKB1, STAT1, IL6, TNF) and inflammation-related pathways potentially modulated by the formula's compounds (PMID 32489026).
  • Anti-inflammatory quality evaluation: a 2020 Journal of Ethnopharmacology study built a chemical-fingerprinting quality standard (15 marker compounds across 11 herbs) and found dose-dependent anti-inflammatory effects in zebrafish and mouse macrophage models, associated with suppression of NF-κB and STAT3 signaling (PMID 32730890).
  • COVID-19 (mini review, 2020): a review summarizing the formula's documented antiviral, anti-inflammatory, antipyretic, and immunomodulatory effects against related viral illnesses (SARS, H1N1, EV71) as a theoretical basis for adjunctive COVID-19 use; direct COVID-19 clinical data were explicitly noted as limited at the time of publication (PMID 32454888).
  • Sepsis (protocol only, not completed results): a 2019 PROSPERO-registered (CRD42019123078) systematic-review protocol proposed to evaluate the formula for sepsis against outcomes including 28-day mortality, blood pressure, lactate, and inflammatory markers; this citation is the study design, not reported findings (PMID 30817635).

  Sources: PubMed 32489026; PubMed 32730890; PubMed 32454888 (PMC 7235554, DOI 10.1186/s13020-020-00332-y); PubMed 30817635 (protocol/registration only). Research context, not a therapeutic claim; direct completed-trial clinical evidence remains limited.